ANIK Anika Therapeutics Inc

Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

$20.54  -0.63 (-2.98%)
As of 05/24/2022 10:30:14 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2001
Outstanding shares:  14,543,860
Average volume:  109,101
Market cap:   $305,130,183
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2035754

---

Valuation   (See tab for details)

---

PE ratio:   -188.08
PB ratio:   1.08
PS ratio:   2.03
Return on equity:   -0.57%
Net income %:   -1.09%